A national clinical quality registry for melanoma – A major strategy to improve patient outcomes

Clinically amelanotic/hypomelanotic melanoma: Anatomic location, risk factors and survival

Phenotypic and genotypic analysis of amelanotic melanoma patients drawn from a Queensland case-control study

Appropriate cancer surveillance plan for the BAP1 positive patient: A proposed interdisciplinary consensus strategy

A close shave: Population trends in biopsy methods used to diagnose melanoma and impacts on microstaging and management

Ongoing high quality randomised trials investigating the role of radiotherapy for melanoma in a changing treatment landscape

Linear basel cell carcinoma’s

Vismodegib: Challenges and experiences in the Pharmaceutical Benefits Scheme era